MarketInOut Stock Screener Log In | Sign Up

Alamar Biosciences Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 10/30/2026
Alamar Biosciences Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,387.11 mln
Float35.83 mln
Earnings Date11/03/2026

1-Year Forecast

35.40
Attractive

Relative Strength

97 / 100
Top performer

Debt / Equity

0.16
Very low leverage

Pre-Tax Margin

-62%
Severely loss-making

ROE

-51.23
Deeply negative

Altman Z-Score

14.91
Exceptional

Business Description

Alamar Biosciences, founded in 2018 and headquartered in Fremont, California, makes tools that help scientists detect and measure proteins in the blood to identify diseases at an early stage. Its flagship ARGO system automates this process with exceptional sensitivity, supporting research across fields such as cancer, neurology, and immunology. The company serves universities, drug developers, and research labs across North America, Europe, the Middle East, and Asia Pacific.

Key Fundamentals

EPS-1.20
ROE-51.23
RPS4.24
ROIC-22.58
ROA-11.96
Interest Cover-57.89
EBITDA, mln-31.41
EV / EBITDA-64.23
EV / EBIT-59.84
Revenue, mln55.46
EV / Revenue36.37

Quote Details

Last 30.60
Change -3.44 (-10.11%)
Open 33.35
Volume 739,941
Turnover 22,642,194
Average Volume 804,704

Financial Ratios

Pre-Tax Profit Margin-62
Leverage Ratio1.25
Current Ratio11.85
Price / Book7.08
Price / Tangible Book7.11
Debt / Equity0.16
Price / Sales39.91

Financial Strength

Altman Z-Score14.91
1-Year Target Price35.40
Short Ratio3.53
Short % of Float6.25

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.29% 46 / 100   
1 Month -5.73% 38 / 100   
2 Months 25.41% 94 / 100   
6 Months 18.56% 89 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog